Patents by Inventor Jun Morimura
Jun Morimura has filed for patents to protect the following inventions. This listing includes patent applications that are pending as well as patents that have already been granted by the United States Patent and Trademark Office (USPTO).
-
Patent number: 11856084Abstract: Embodiments facilitate interoperability and secure determination of healthcare costs. An entity may receive a first Electronic Health Record (EHR) sub-block with patient medical coverage information and first treatments and may transmit a first Device Drug Information (DIR) sub-block comprising first treatment classes corresponding to each first treatment, first treatment class members corresponding to each first treatment class, and corresponding first treatment class member cost information. In response, the entity may receive a second EHR sub-block comprising second treatments each: associated with a corresponding first treatment, and selected from corresponding first treatment class members. Upon receipt of a transaction confirmation, the entity may augment a multi-dimensional blockchain with a multi-dimensional block formed by linking: a DIR block including second treatment information, an EHR block including information based on the second EHR sub-block and a transaction block.Type: GrantFiled: December 15, 2022Date of Patent: December 26, 2023Assignee: Janssen Pharmaceutica NVInventors: Jessica Lee, Jun Morimura, Michael Moschetti, John Vig, Marvin Quesada, Andrew Thomson
-
Patent number: 11848080Abstract: Embodiments facilitate interoperability and secure patient selection for clinical trials and drug/device deployments. An entity may obtain a first set of health parameters and collective demographic information associated with one or more population segments and receive Electronic Health Record (EHR) sub-blocks with patient profile information and corresponding patient medical histories for patients. The entity may determine a subset of eligible candidate patients for a treatment based on information in the EHR sub-blocks and eligibility criteria for the treatment, which may be based the first set of health parameters, and/or the collective demographic information.Type: GrantFiled: December 15, 2022Date of Patent: December 19, 2023Assignee: Janssen Pharmaceutica NVInventors: Jessica Lee, Jun Morimura, Michael Moschetti, John Vig, Marvin Quesada, Andrew Thomson
-
Publication number: 20230138488Abstract: Embodiments facilitate interoperability and secure determination of healthcare costs. An entity may receive a first Electronic Health Record (EHR) sub-block with patient medical coverage information and first treatments and may transmit a first Device Drug Information (DIR) sub-block comprising first treatment classes corresponding to each first treatment, first treatment class members corresponding to each first treatment class, and corresponding first treatment class member cost information. In response, the entity may receive a second EHR sub-block comprising second treatments each: associated with a corresponding first treatment, and selected from corresponding first treatment class members. Upon receipt of a transaction confirmation, the entity may augment a multi-dimensional blockchain with a multi-dimensional block formed by linking: a DIR block including second treatment information, an EHR block including information based on the second EHR sub-block and a transaction block.Type: ApplicationFiled: December 15, 2022Publication date: May 4, 2023Inventors: Jessica Lee, Jun Morimura, Michael Moschetti, John Vig, Marvin Quesada, Andrew Thomson
-
Publication number: 20230118275Abstract: Embodiments facilitate interoperability and secure patient selection for clinical trials and drug/device deployments. An entity may obtain a first set of health parameters and collective demographic information associated with one or more population segments and receive Electronic Health Record (EHR) sub-blocks with patient profile information and corresponding patient medical histories for patients. The entity may determine a subset of eligible candidate patients for a treatment based on information in the EHR sub-blocks and eligibility criteria for the treatment, which may be based the first set of health parameters, and/or the collective demographic information.Type: ApplicationFiled: December 15, 2022Publication date: April 20, 2023Inventors: Jessica Lee, Jun Morimura, Michael Moschetti, John Vig, Marvin Quesada, Andrew Thomson
-
Patent number: 11539506Abstract: Embodiments facilitate interoperability and secure determination of healthcare costs. An entity may receive a first Electronic Health Record (EHR) sub-block with patient medical coverage information and first treatments and may transmit a first Device Drug Information (DIR) sub-block comprising first treatment classes corresponding to each first treatment, first treatment class members corresponding to each first treatment class, and corresponding first treatment class member cost information. In response, the entity may receive a second EHR sub-block comprising second treatments each: associated with a corresponding first treatment, and selected from corresponding first treatment class members. Upon receipt of a transaction confirmation, the entity may augment a multi-dimensional blockchain with a multi-dimensional block formed by linking: a DIR block including second treatment information, an EHR block including information based on the second EHR sub-block and a transaction block.Type: GrantFiled: January 14, 2021Date of Patent: December 27, 2022Assignee: Janssen Pharmaceutica NVInventors: Jessica Lee, Jun Morimura, Michael Moschetti, John Vig, Marvin Quesada
-
Patent number: 11532385Abstract: Embodiments facilitate interoperability and secure patient selection for clinical trials and drug/device deployments. An entity may obtain a first set of health parameters and collective demographic information associated with one or more population segments and receive Electronic Health Record (EHR) sub-blocks with patient profile information and corresponding patient medical histories for patients. The entity may determine a subset of eligible candidate patients for a treatment based on information in the EHR sub-blocks and eligibility criteria for the treatment, which may be based the first set of health parameters, and/or the collective demographic information.Type: GrantFiled: January 14, 2021Date of Patent: December 20, 2022Assignee: Janssen Pharmaceutica NVInventors: Jessica Lee, Jun Morimura, Michael Moschetti, John Vig, Marvin Quesada
-
Publication number: 20210151136Abstract: Embodiments facilitate interoperability and secure patient selection for clinical trials and drug/device deployments. An entity may obtain a first set of health parameters and collective demographic information associated with one or more population segments and receive Electronic Health Record (EHR) sub-blocks with patient profile information and corresponding patient medical histories for patients. The entity may determine a subset of eligible candidate patients for a treatment based on information in the EHR sub-blocks and eligibility criteria for the treatment, which may be based the first set of health parameters, and/or the collective demographic information.Type: ApplicationFiled: January 14, 2021Publication date: May 20, 2021Inventors: Jessica Lee, Jun Morimura, Michael Moschetti, John Vig, Marvin Quesada
-
Publication number: 20210135841Abstract: Embodiments facilitate interoperability and secure determination of healthcare costs. An entity may receive a first Electronic Health Record (EHR) sub-block with patient medical coverage information and first treatments and may transmit a first Device Drug Information (DIR) sub-block comprising first treatment classes corresponding to each first treatment, first treatment class members corresponding to each first treatment class, and corresponding first treatment class member cost information. In response, the entity may receive a second EHR sub-block comprising second treatments each: associated with a corresponding first treatment, and selected from corresponding first treatment class members. Upon receipt of a transaction confirmation, the entity may augment a multi-dimensional blockchain with a multi-dimensional block formed by linking: a DIR block including second treatment information, an EHR block including information based on the second EHR sub-block and a transaction block.Type: ApplicationFiled: January 14, 2021Publication date: May 6, 2021Inventors: Jessica Lee, Jun Morimura, Michael Moschetti, John Vig, Marvin Quesada
-
Patent number: 10931437Abstract: Disclosed embodiments facilitate healthcare system security and interoperability. In some embodiments, a first entity may receive, in response to a transaction at a first time, encrypted information blocks pertaining to the transaction from one or more second entities. Each encrypted information block may be received from a distinct second entity and may comprise at least one sub-block decryptable by the first entity. The first entity may decrypt the decryptable sub-blocks and augment a multi-dimensional blockchain. The multi-dimensional blockchain may be augmented with a multi-dimensional block formed by linking at least one of the encrypted information blocks received from the one or more second entities to a current block being added to a blockchain associated with the transaction and maintained by the first entity. The first entity may then enable access to the multi-dimensional blockchain for at least one of the one or more second entities.Type: GrantFiled: December 4, 2019Date of Patent: February 23, 2021Assignee: Janssen Pharmaceutica NVInventors: Jun Morimura, Jessica Lee, Rama Kondru, Thomas Doyle, Lichen Shen
-
Publication number: 20210027896Abstract: Various aspects of the subject technology relate to systems, methods, and machine-readable media for a learning platform that employs machine learning to identify patterns that describe meaningful subgroups of patients associated with a particular disease, distinct characteristics of each subgroup, and implications of belonging to a specific subgroup in terms of developing into a more severe disease state for patient journey mapping. The system may include a mapping server that includes a medical-event embedding engine that embeds electronic health records into vectors, a clustering engine that identifies clusters of patients with similar patient journeys by operating on the output of the medical-event embedding engine, and a cluster profiling engine that identifies distinguishing medical events for each identified cluster by operating on the output of the clustering engine.Type: ApplicationFiled: July 23, 2020Publication date: January 28, 2021Inventors: Ye Jin Eun, Wei Wang, Xiaoying Wu, Jun Morimura, Geoffrey Townsend Red
-
Publication number: 20200235909Abstract: Disclosed embodiments facilitate healthcare system security and interoperability. In some embodiments, a first entity may receive, in response to a transaction at a first time, encrypted information blocks pertaining to the transaction from one or more second entities. Each encrypted information block may be received from a distinct second entity and may comprise at least one sub-block decryptable by the first entity. The first entity may decrypt the decryptable sub-blocks and augment a multi-dimensional blockchain. The multi-dimensional blockchain may be augmented with a multi-dimensional block formed by linking at least one of the encrypted information blocks received from the one or more second entities to a current block being added to a blockchain associated with the transaction and maintained by the first entity. The first entity may then enable access to the multi-dimensional blockchain for at least one of the one or more second entities.Type: ApplicationFiled: December 4, 2019Publication date: July 23, 2020Inventors: Jun Morimura, Jessica Lee, Rama Kondru, Thomas Doyle, Lichen Shen
-
Patent number: 10541807Abstract: Disclosed embodiments facilitate healthcare system security and interoperability. In some embodiments, a first entity may receive, in response to a transaction at a first time, encrypted information blocks pertaining to the transaction from one or more second entities. Each encrypted information block may be received from a distinct second entity and may comprise at least one sub-block decryptable by the first entity. The first entity may decrypt the decryptable sub-blocks and augment a multi-dimensional blockchain. The multi-dimensional blockchain may be augmented with a multi-dimensional block formed by linking at least one of the encrypted information blocks received from the one or more second entities to a current block being added to a blockchain associated with the transaction and maintained by the first entity. The first entity may then enable access to the multi-dimensional blockchain for at least one of the one or more second entities.Type: GrantFiled: January 18, 2019Date of Patent: January 21, 2020Assignee: Janssen Pharmaceutica NVInventors: Jun Morimura, Jessica Lee, Rama Kondru, Thomas Doyle, Lichen Shen